Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1

Author(s): Puthanveetil P, Zhang D, Wang Y, Wang F, Wan A, et al.

Abstract

Cardiomyocyte cell death is a major contributing factor for diabetic cardiomyopathy, and multiple mechanisms have been proposed for its development. We hypothesized that following diabetes, an increased nuclear presence of the Forkhead transcription factor, FoxO1, could turn on cardiac cell death through mediation of nitrosative stress. Streptozotocin (100 mg/kg) was used to induce irreversible hyperglycemia in Wistar rats, and heart tissues and blood samples extracted starting from 1 to 4 days. Diazoxide (100 mg/kg), which produced acute reversible hyperglycemia, were followed for up to 12 h. In both animal models of hyperglycemia, attenuation of survival signals was accompanied by increased nuclear FoxO1. This was accompanied by a simultaneous increase in iNOS expression and iNOS induced protein nitrosylation of GAPDH, increased GAPDH binding to Siah1 and facilitated nuclear translocation of the complex. Even though caspase-3 was cleaved during diabetes, its nitrosylation modification affected its ability to inactivate PARP. As a result, there was PARP activation followed by nuclear compartmentalization of AIF, and increased phosphatidyl serine externalization. Our data suggests a role for FoxO1 mediated iNOS induced S-nitrosylation of target proteins like GAPDH and caspase-3 in initiating cardiac cell death following hyperglycemia, and could explain the impact of glycemic control in preventing cardiovascular disease in patients with diabetes.

Similar Articles

Diabetes and the risk of heart failure

Author(s): Dhingra R, Vasan RS

Pathophysiology of myocardial reperfusion

Author(s): Fox KA, Bergmann SR, Sobel BE

Chronic pharmacological preconditioning against ischemia

Author(s): Luca MC, Liuni A, Muxel S, Münzel T, Forconi S, et al.

Myocardial fatty acid metabolism in health and disease

Author(s): Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC

FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress

Author(s): Sengupta A, Molkentin JD, Paik JH, DePinho RA, Yutzey KE

FoxO, autophagy, and cardiac remodeling

Author(s): Ferdous A, Battiprolu PK, Ni YG, Rothermel BA, Hill JA

The FoxO family in cardiac function and dysfunction

Author(s): Ronnebaum SM, Patterson C

Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice

Author(s): Battiprolu PK, Hojayev B, Jiang N, Wang ZV, Luo X, et al.

Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts

Author(s): Akiyama N, Okumura K, Watanabe Y, Hashimoto H, Ito T, et al.

Glucose for the heart

Author(s): Depre C, Vanoverschelde JL, Taegtmeyer H

Hibernating myocardium

Author(s): Wijns W, Vatner SF, Camici PG

Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study

Author(s): Leung AA, Eurich DT, Lamb DA, Majumdar SR, Johnson JA, et al.

Phosphatases at the heart of FoxO metabolic control

Author(s): Tremblay ML, Giguère V

Adiponectin in the heart and vascular system

Author(s): Ding M, Rzucidlo EM, Davey JC, Xie Y, Liu R, et al.

The role of FoxO in the regulation of metabolism

Author(s): Gross DN, van den Heuvel AP, Birnbaum MJ

FoxO transcription factors; Regulation by AKT and 14-3-3 proteins

Author(s): Tzivion G, Dobson M, Ramakrishnan G

Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction

Author(s): Parisi Q, Biondi-Zoccai GG, Abbate A, Santini D, Vasaturo F, et al.

Silent information regulator 1 protects the heart from ischemia/reperfusion

Author(s): Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, et al.

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

Author(s): Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al.

Oxidative stress, nitric oxide, and diabetes

Author(s): Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, et al.

Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure

Author(s): Mehra A, Shotan A, Ostrzega E, Hsueh W, Vasquez-Johnson J, et al.

Influence of diabetes mellitus on heart failure risk and outcome

Author(s): Bauters C, Lamblin N, Mc Fadden EP, Van Belle E, Millaire A, et al.

Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism

Author(s): Philip-Couderc P, Tavares NI, Roatti A, Lerch R, Montessuit C, et al.

An essential role of the JAK-STAT pathway in ischemic preconditioning

Author(s): Xuan YT, Guo Y, Han H, Zhu Y, Bolli R

Preconditioning the diabetic heart: the importance of Akt phosphorylation

Author(s): Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM